Phase 4 multi-center, randomized, double blind, placebo-controlled study of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis

Trial Profile

Phase 4 multi-center, randomized, double blind, placebo-controlled study of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis

Planning
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Sarcoidosis
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top